| Literature DB >> 36120271 |
Meenakshi R Verma1, Deepakkumar G Langade2, Rahul D Rao1, Shreya Shivangi1, Sonali Khedkar3, Divya Kanchibhotla4.
Abstract
Introduction One of the major health problems in many countries including India is type 2 diabetes. Yoga is being explored as an alternative therapy for the management of diabetes. Methods Among the total of 137 participants who successfully completed the 'Living Well' workshop by the Art of Living, 84 with type 2 diabetes were assessed for change in random blood sugar levels, systolic and diastolic blood pressure levels (SBP/DBP), and pulse rate over seven days. In the Living Well workshop, the participants performed a comprehensive Yogic Breathing Program that included yogic movements and postures (Asana), relaxation practice, three-stage Pranayama, Sudarshan Kriya Yoga (SKY), breathing techniques, and discussion of stress relieving principles over those seven days. The parameters were recorded at the time of enrollment and after the completion of seven days of the workshop. Results There was a greater (p<0.05) percent reduction in the mean blood sugar level in diabetics as compared to non-diabetic individuals. However, the reduction in SBP and DBP were similar (p>0.05) in diabetics and non-diabetics. The percent reduction in the pulse rate however was greater (p<0.05) in diabetics than non-diabetics. Conclusion Comprehensive yogic breathing practices comprising SKY may be beneficial in patients with type 2 diabetes mellitus.Entities:
Keywords: alternative therapy; diabetes mellitus; living well; sudarshan kriya; yoga
Year: 2022 PMID: 36120271 PMCID: PMC9464970 DOI: 10.7759/cureus.27951
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Percentage change from baseline in BSL in diabetic and non-diabetic participants
Error bars are 95% confidence intervals for mean of % change
BSL, blood sugar level
Figure 4Percentage change from baseline in pulse rate in diabetic and non-diabetic participants
Error bars are 95% confidence intervals for mean of % change
Percent change from baseline in BSL, SBP, DBP, and PR
*ANCOVA (analysis of covariance) with hypertension, hypercholesterolemia, presence of back pain, and gender as covariates. **p-value of <0.05 is considered significant
SBP, systolic blood pressure; DBP, diastolic blood pressure; PR, pulse rate; BSL, blood sugar level
| Diabetic (n=84) | Non-diabetic (n=53) | ||||
| Mean | 95% CI | Mean | 95% CI | p-Value* | |
| Blood sugar (mg%) | -22.85 | -27.70 to -18.01 | -12.59 | -17.84 to -7.33 | 0.0057** |
| SBP (mm Hg) | -3.59 | -7.95 to 0.77 | -0.94 | -5.62 to 3.74 | 0.4180 |
| DBP (mm Hg) | -4.60 | -8.66 to -0.54 | -0.57 | -4.92 to 3.78 | 0.1870 |
| PR (per minute) | -6.51 | -10.77 to -2.24 | -4.95 | -9.52 to -0.37 | 0.6260 |
| Mean arterial pressure (mm Hg) | -4.24 | -8.28 to -0.19 | -0.84 | -5.17 to 3.49 | 0.2630 |
Demographics and baseline characteristics in the two groups
*p-value of <0.05 is considered significant
CVD, cardiovascular disease; SD, standard deviation
| Diabetic | Non-Diabetic | p-Value | |
| No. of participants, N | 84 | 53 | |
| Male/female, N (%) | 52/32 (61.90%/38.10%) | 25/28 (47.16%/52.83%) | 0.0916 (chi-square test) |
| Age (years), mean (SD) | 50.35 (10.24) | 48.69 (9.52) | 0.3442 (independent sample t-test) |
| Body weight (kg), mean (SD) | 72.70 (12.45) | 76.46 (11.92) | 0.0824 (independent sample t-test) |
| Hypertensive, N (%) | 35 (41.66%) | 18 (33.96%) | 0.3692 (Fischer's test) |
| History of CVD, N (%) | 14 (16.66%) | 3 (5.66%) | 0.0580* (Fischer's test) |
Figure 2Percentage change from baseline in SBP in diabetic and non-diabetic participants
Error bars are 95% confidence intervals for mean of % change
SBP, systolic blood pressure
Figure 3Percentage change from baseline in DBP in diabetic and non-diabetic participants
Error bars are 95% confidence intervals for mean of % change
DBP, diastolic blood pressure